Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a once-weekly injection. It’s administered with a tiny needle that punctures ...

"Lilly’s orforglipron trumps oral semaglutide in head-to-head trial" was originally created and published by Clinical Trials Arena, a GlobalData owned brand.

You might already know that it's important to eat enough protein while taking a weight-loss medication, but a new study explains why this macro is so essential. People on weight-loss drugs often lose ...

Eli Lilly's orforglipron outperformed Novo Nordisk’s semaglutide for type 2 diabetes, showing greater weight loss and blood ...